Eczema (Atopic Dermatitis) and Food Allergies (IgE- and non–IgE–mediated)

Deep Dive

From a western clinical lens, eczema and food allergies share a common atopic foundation but are not interchangeable. Epidemiology highlights th... From a western clinical lens, eczema and food allergies share a common atopic foundation but are not interchangeable. Epidemiology highlights their overlap: children with atopic dermatitis, particularly those with early onset and moderate–to–severe disease, have markedly higher odds of food allergy confirmed by oral food challenge. Mechanistic studies explain why. Defects in the epidermal barrier—including filaggrin loss‑of‑function variants—allow environmental food proteins to penetrate through inflamed skin. Keratinocyte alarmins like TSLP and IL‑33 prompt a type‑2 immune cascade (IL‑4/IL‑13), driving IgE class switching. Environmental peanut protein in dust has been associated with increased sensitization in households with atopic children, reinforcing the importance of the skin as an immune gateway. Clinically, two patterns are important to distinguish. Immediate, IgE‑mediated reactions occur within minutes to two hours of ingestion and can include hives, vomiting, wheeze, or anaphylaxis. Delayed eczematous flares after food exposure can occur but are harder to prove and are less common than many families expect. Because skin prick tests and serum specific IgE detect sensitization rather than clinical reactivity, they have limited positive predictive value when used broadly in eczema. Component‑resolved diagnostics (e.g., Ara h 2 for peanut) can refine risk but do not replace the gold‑standard oral food challenge, which remains the definitive test when the history is equivocal. Management balances skin care with safe nutrition. For eczema, barrier repair with emollients, topical anti‑inflammatories, infection control, and trigger minimization are foundational. For confirmed food allergy, strict avoidance, nutrition counseling, and emergency preparedness are central; omalizumab and oral immunotherapy are options in select settings. Importantly, early introduction of peanut—and with appropriate protocols, egg—reduces the development of food allergy in high‑risk infants and does not worsen eczema. Broad elimination diets without clear evidence of allergy can lead to nutritional compromise and should be avoided. Coordinated care between dermatology, allergy, and nutrition helps families target testing, avoid over‑restriction, and periodically reassess for tolerance as many children outgrow milk and egg allergies.